Medication Assisted Treatment (MAT). Provider shall provide clinical medical care for substance use disorder to affected Inmates. This includes, but is not limited to, monitoring for and treatment of alcohol, opioid and benzodiazepine withdrawal using nationally accepted guidelines and tools; medication assisted withdrawal and medication assisted treatment for opioid use disorder; coordination with community based treatment facilities and opioid treatment programs to ensure seamless transition of Inmates from community treatment to treatment within DDOC facilities and vice versa. (This includes ensuring coordination with opioid treatment programs to ensure methadone continuation for those who received methadone in the community but are now incarcerated). Provider will ensure that each facility has available (onsite or by telemedicine) a medical provider who is able to evaluate patients with a history suggestive of substance use disorder and to make recommendations to initiate or continue (as appropriate) medication assisted treatment or medication assisted withdrawal within 48 hours of the Inmates’ incarceration (for non-pregnant inmates) and within 12 hours of incarceration for pregnant Inmates. It is Provider’s responsibility to ensure that it has a sufficient number of duly trained and credentialed (and DATA/CARA waivered) providers to meet the needs of all inmates with substance use and co-occurring disorders. Refer to DDOC Policy F-04 Medically Assisted Withdrawal and Treatment. Provider shall have a local Opioid Treatment Program (“OTP”), and it will be required to have a formal arrangement, approved by DDOC, with local OTP providers to ensure continuation of treatment for Inmates coming into DDOC who were treated with MAT in the community. DDOC requires that Provider is capable of administering all FDA-approved medications for the treatment of substance use disorder, including as appropriate, continuation of those who were on MAT in the community, and induction of therapy for those not previously on MAT, but who would benefit from MAT during incarceration. The costs of all medications related to MAT will be borne by the Pharmacy Contractor, not Provider.
Medication Assisted Treatment (MAT). “Medication Assisted Treatment” is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of SUDs.
Medication Assisted Treatment (MAT). Is an evidence-based practice that combines pharmacological interventions with substance abuse counseling and social support.
Medication Assisted Treatment (MAT) is a standard of care that is broadly recognized as an essential pillar in any comprehensive approach to the national opioid addiction and overdose epidemic. The State of Michigan seeks to ensure that no consumer is denied access to or pressured to reject the full-service array of evidence-based and potentially life-saving treatment options, including MAT, that are determined to be medically necessary for the individualized needs of that consumer. Treatment options should be discussed in an objective way so each consumer can make an informed decision based on research and outcome data. The State of Michigan expects that PIHP-contracted SUD treatment providers will do the following:
a. Adopt a MAT-inclusive treatment philosophy that recognizes multiple pathways to recovery;
b. Reject pressuring MAT clients to adopt a tapering schedule and/or a mandated period of abstinence;
c. Develop and/or strengthen policies that prohibit disparaging, delegitimizing, and/or stigmatizing of MAT either with individual clients or in the public domain;
d. When a consumer on MAT (or considering MAT) is seeking treatment services at the point of access, access staff will respect MAT as a choice without judgment, stigma, or pressure to change recovery pathways. If a provider does not have capacity to work with a person receiving MAT, the provider will work with the consumer and LRE or appropriate Access Departments to facilitate a warm handoff/transfer to another provider, who can provide ancillary services (counseling, case management, recovery supports, recovery housing) while the client pursues his or her chosen recovery pathway.
Medication Assisted Treatment (MAT). MAT covers approved medications in combination with behavioral therapies to provide a whole client approach to treating substance use disorders. Clients seeking Outpatient, Residential or Recovery Residences services and have concurrent MAT shall not be delayed access to substance use disorder treatment and recovery services due to the client’s medical status as it relates to MAT. Providers shall develop a policy, which includes how the program informs clients and educates staff about the MAT available at the program if applicable. The policy shall also include the assessment of a client’s MAT needs, administration and storage of medications, and training of staff. Provider staff shall be trained in the area of MAT protocols to include all portions of these standards pertaining to monitoring of persons undergoing detoxification. If, while in treatment, a client exhibits signs and symptoms of withdrawal or behaviors that is a cause for concern for the provider and is believed to be attributable to the client’s medication, the SUS treatment provider staff should address this clinically with the client and the client prescriber. Treatment plans shall be flexible and adjusted as needed with review and consultation by the prescribing physician. Provider staff will regularly communicate with physicians of beneficiaries who are prescribed these medications unless the beneficiary refuses to consent to sign a 42 CFR part 2 compliant release of information for this purpose.
